TGFβ1 and HGF protein secretion by esophageal squamous epithelial cells and stromal fibroblasts in oesophageal carcinogenesis

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 401-406

  Xu, Zhibin ^a   Wang, Shijie ^a   Wu, Mingli ^a   Zeng, Weiwei ^a   Wang, Xiaoling ^a   Dong, Zhiming ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

smooth muscle actin; Esophageal squamous cell carcinoma; Fibroblast; Hepatocyte growth factor; Transforming growth factor 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; CARCINOGENESIS; CARCINOMA IN SITU; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; PROTEIN EXPRESSION; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA;

EID: 84879476461     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1409     Document Type: Article

References (34)

1. Wei WQ, Qiao YL, Wang GQ, et al: Progress in prevention and control of esophageal carcinoma in high-risk population. J Pract Oncol 6: 371-373, 2001 (In Chinese).
2. Martin de Civetta MT and Civetta JD: Carcinogenesis. Salud Publica Mex 53: 405-414, 2011 (In Spanish).
3. Weiss RA: Multistage carcinogenesis. Br J Cancer 12: 1981-1982, 2004.
4. Xing F, Saidou J and Watabe K: Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 15: 166-179, 2010.
5. Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337, 2004.
6. Sugimoto H, Mundel TM, Kieran MW and Kalluri R: Identification of fibroblast heterogeneity in the tumour microenvironment. Cancer Biol Ther5: 1640-1646, 2006.
7. Erez N, Ttuitt M, Olson P, et al: Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumour-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell17: 135-147, 2010.
8. Zhang B, Halder SK, Zhang S and Datta PK: Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer. Cancer Lett 277: 114-120, 2009.
9. Gholamin M, Moaven O, Memar B, et al: Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma. World J Surg 33: 1439-1445, 2009.
10. Langenskiöld M, Holmdahl L, Falk P, et al: Increased TGF-beta 1 protein expression in patients with advanced colorectal cancer. J Surg Oncol 97: 409-415, 2008.
11. Hawinkels LJ, Verspaget HW, van Duijn W, et al: Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients. Br J Cancer 97: 398-404, 2007.
12. Matsumoto K, Date K, Ohmichi H, et al: Hepatocyte growth factor in lung morphogenesis and tumour invasion: role as a mediator in epithelium-mesenchyme and tumour-stroma interactions. Cancer Chemother Pharmacol 38 (Suppl): S42-S47, 1996.
13. Uchida D, Kawamata H, Omotehara F, et al: Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int JCancer93: 489-496, 2001.
14. Zhou Q, Dong Wang L, Du F, et al: Changes of TGFbeta1 and TGFbetaRII expression in esophageal precancerous and cancerous lesions: a study of a high-risk population in Henan, northern China. Dis Esophagus 15: 74-79, 2002.
15. Ren Y, Cao B, Law S, et al: Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res 11: 6190-6197, 2005.
16. Takada N, Yano Y, Matsuda T, et al: Expression of immunoreactive human hepatocyte growth factor in human esophageal squamous cell carcinomas. Cancer Lett 97: 145-148, 1995.
17. Bosman FT, Carneiro F, Hruban RH and Theise ND (eds): World Health Organization Classification of Tumours of the Digestive System. IARC Press, Lyon, 2010.
18. El-Shahat M, Lotfy M, Fahmy L, et al: Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 protein expression in esophageal cancer. J Egypt Natl Canc Inst16: 224-230, 2004.
19. Rønnov-Jessen L, Petersen OW and Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76: 69-125, 1996.
20. Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503, 2003.
21. Mueller MM and Fusenig NE: Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849, 2004.
22. Fuyuhiro Y, Yashiro M, Noda S, et al: Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells. Br J Cancer 105: 996-1001, 2011.
23. Abe R, Donnelly SC, Peng T, et al: Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. JImmunol166: 7556-7562, 2001.
24. Tuxhorn JA, McAlhany SJ, Yang F, et al: Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res62: 6021-6025, 2002.
25. Brenmoehl J, Miller SN, Hofmann C, et al: Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration. World J Gastroenterol 15: 1431-1442, 2009.
26. Masszi A, Di Ciano C, Sirokmány G, et al: Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol284: F911-F924,2003.
27. Von Rahden BH, Stein HJ, Feith M, et al: Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis. Mol Carcinog45: 786-794, 2006.
28. Herrera LJ, El-Hefnawy T, Queiroz de Oliveira PE, et al: The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. Neoplasia 7: 75-84, 2005.
29. Noma K, Smalley KS, Lioni M, et al: The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 134: 1981-1993, 2008.
30. Saito H, Tsujitani S, Oka S, et al: The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer86: 1455-1462, 1999.
31. Grugan KD, Miller CG, Yao Y, et al: Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci USA107: 11026-11031, 2010.
32. Oshima Y, Yajima S, Yamazaki K, et al: Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinoma. Ann Thorac Cardiovasc Surg16: 389-393, 2010.
33. Kuperwasser C, Chavarria T, Wu M, et al: Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101: 4966-4971, 2004.
34. Bhowmick NA, Chytilt A, Plieth D, et al: TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848-851, 2004.